The spray treats inflammation in the brain and reduces it so that the patient's thinking and memory will no longer ...

Nick Kyrgios believes the tennis world has ‘been played’ after Jannik Sinner announced that he has reappointed his former ...

Jannik Sinner has reappointed Umberto Ferrara, the fitness coach who was inadvertently involved in his three-month doping ban ...

Key Takeaways An insulin nasal spray might be a potential treatment for Alzheimer’s diseaseBrain scans show insulin travels ...

The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older ...

Scientists have, for the first time, tracked nasal insulin traveling into the brain—revealing why it may work differently in ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for EURneffy, an adrenaline ...

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

A small dog was saved by Washington firefighters using Narcan after it was found unresponsive due to fentanyl exposure.

US FDA accepts for review Milestone Pharma’s response to CRL for Cardamyst nasal spray: Montreal Monday, July 14, 2025, 11:00 Hrs [IST] Milestone Pharmaceuticals Inc., a biophar ...

FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support potential PSVT treatment launch.